These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26209789)

  • 1. Depressive symptoms predict future simple disease activity index scores and simple disease activity index remission in a prospective cohort of patients with early inflammatory polyarthritis.
    Leblanc-Trudeau C; Dobkin PL; Carrier N; Cossette P; de Brum-Fernandes AJ; Liang P; Masetto A; Boire G
    Rheumatology (Oxford); 2015 Dec; 54(12):2205-14. PubMed ID: 26209789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes.
    Ruyssen-Witrand A; Guernec G; Nigon D; Tobon G; Jamard B; Rat AC; Vittecoq O; Cantagrel A; Constantin A
    Ann Rheum Dis; 2015 Sep; 74(9):1676-83. PubMed ID: 24794151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis.
    Kekow J; Moots R; Khandker R; Melin J; Freundlich B; Singh A
    Rheumatology (Oxford); 2011 Feb; 50(2):401-9. PubMed ID: 21059675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of 14-3-3η protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis.
    Carrier N; Marotta A; de Brum-Fernandes AJ; Liang P; Masetto A; Ménard HA; Maksymowych WP; Boire G
    Arthritis Res Ther; 2016 Feb; 18():37. PubMed ID: 26832367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.
    Combe B; Logeart I; Belkacemi MC; Dadoun S; Schaeverbeke T; Daurès JP; Dougados M
    Ann Rheum Dis; 2015 Apr; 74(4):724-9. PubMed ID: 24399234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients.
    Aletaha D; Funovits J; Keystone EC; Smolen JS
    Arthritis Rheum; 2007 Oct; 56(10):3226-35. PubMed ID: 17907167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing remission in clinical practice.
    Mierau M; Schoels M; Gonda G; Fuchs J; Aletaha D; Smolen JS
    Rheumatology (Oxford); 2007 Jun; 46(6):975-9. PubMed ID: 17341506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis--results from the Canadian Early Arthritis Cohort (CATCH).
    Kuriya B; Xiong J; Boire G; Haraoui B; Hitchon C; Pope J; Thorne JC; Tin D; Keystone EC; Bykerk V;
    J Rheumatol; 2014 Nov; 41(11):2161-6. PubMed ID: 25274902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving simplified disease activity index remission in patients with active rheumatoid arthritis is associated with subsequent good functional and structural outcomes in a real-world clinical setting under a treat-to-target strategy.
    Hirano F; Yokoyama W; Yamazaki H; Amano K; Kawakami A; Hayashi T; Tamura N; Yasuda S; Dobashi H; Fujii T; Ito S; Kaneko Y; Matsui T; Okuda Y; Saito K; Suzuki F; Yoshimi R; Sakai R; Koike R; Kohsaka H; Miyasaka N; Harigai M;
    Mod Rheumatol; 2017 Sep; 27(5):811-819. PubMed ID: 27919205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological vulnerability predicts increases in depressive symptoms in individuals with rheumatoid arthritis.
    Sinclair VG; Wallston KA
    Nurs Res; 2010; 59(2):140-6. PubMed ID: 20216016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified Disease Activity Index remission at month 6 is an independent predictor of functional and structural remissions at month 12 during abatacept treatment in patients with rheumatoid arthritis: A multi-center, prospective cohort study in Japan.
    Yamazaki H; Hirano F; Takeuchi T; Amano K; Kikuchi J; Kihara M; Yokoyama W; Sugihara T; Nagasaka K; Hagiyama H; Nonomura Y; Sakai R; Tanaka M; Koike R; Nanki T; Kohsaka H; Miyasaka N; Harigai M
    Mod Rheumatol; 2017 Sep; 27(5):787-794. PubMed ID: 27846756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study.
    Shen J; Shang Q; Wong CK; Li EK; Wang S; Li RJ; Lee KL; Leung YY; Ying KY; Yim CW; Kun EW; Leung MH; Li M; Li TK; Zhu TY; Yu SL; Kuan WP; Yu CM; Tam LS
    Semin Arthritis Rheum; 2015 Aug; 45(1):18-27. PubMed ID: 25798875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of long-term clinical outcome with etanercept treatment and adalimumab treatment of rheumatoid arthritis with respect to immunogenicity.
    Krieckaert CL; Jamnitski A; Nurmohamed MT; Kostense PJ; Boers M; Wolbink G
    Arthritis Rheum; 2012 Dec; 64(12):3850-5. PubMed ID: 22933315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard.
    Balsa A; de Miguel E; Castillo C; Peiteado D; Martín-Mola E
    Rheumatology (Oxford); 2010 Apr; 49(4):683-90. PubMed ID: 20047979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tight control of rheumatoid arthritis in a resource-constrained setting: a randomized controlled study comparing the clinical disease activity index and simplified disease activity index.
    Hodkinson B; Musenge E; Tikly M
    Rheumatology (Oxford); 2015 Jun; 54(6):1033-8. PubMed ID: 25431484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical function continues to improve when clinical remission is sustained in rheumatoid arthritis patients.
    Radner H; Alasti F; Smolen JS; Aletaha D
    Arthritis Res Ther; 2015 Aug; 17(1):203. PubMed ID: 26259838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of depression, anxiety, fatigue, and fibromyalgia on the evaluation of the remission status in patients with rheumatoid arthritis.
    Inanc N; Yilmaz-Oner S; Can M; Sokka T; Direskeneli H
    J Rheumatol; 2014 Sep; 41(9):1755-60. PubMed ID: 25086073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and the optimal duration of sustained remission in rheumatoid arthritis.
    Yilmaz-Oner S; Gazel U; Can M; Atagunduz P; Direskeneli H; Inanc N
    Clin Rheumatol; 2019 Nov; 38(11):3033-3039. PubMed ID: 31270696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.
    Klarenbeek NB; Koevoets R; van der Heijde DM; Gerards AH; Ten Wolde S; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2011 Oct; 70(10):1815-21. PubMed ID: 21813548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy.
    Barnabe C; Homik J; Barr SG; Martin L; Maksymowych WP
    J Rheumatol; 2014 Aug; 41(8):1607-13. PubMed ID: 25028371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.